Evidence map›Paper›PMID 32708743›Full record

Trial reportNutrients2020

Effect of a Nutritional Intervention on the Intestinal Microbiota of Vertically HIV-Infected Children: The Pediabiota Study.

Talía Sainz, María José Gosalbes, Alba Talavera-Rodríguez, Nuria Jimenez-Hernandez, Luis Prieto, Luis Escosa, Sara Guillén, José Tomás Ramos, María Ángeles Muñoz-Fernández, Andrés Moya and 3 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Talía SainzServicio de Pediatría, Hospital Universitario La Paz and IdiPAZ, 28046 Madrid, Spain.
María José GosalbesÁrea Genómica y Salud, Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO), 46010 Valencia, Spain.
Alba Talavera-RodríguezBioinformatics Unit, Hospital Universitario Ramón y Cajal and IRYCIS, 28034 Madrid, Spain.ORCID 0000-0002-4696-8039
Nuria Jimenez-HernandezÁrea Genómica y Salud, Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO), 46010 Valencia, Spain.
Luis PrietoRed de Investigación CoRISpe integrada en la Red en Infectología Pediátrica (RITIP), 28046 Madrid, Spain.
Luis EscosaServicio de Pediatría, Hospital Universitario La Paz and IdiPAZ, 28046 Madrid, Spain.
Sara GuillénRed de Investigación CoRISpe integrada en la Red en Infectología Pediátrica (RITIP), 28046 Madrid, Spain.ORCID 0000-0001-8204-1858
José Tomás RamosRed de Investigación CoRISpe integrada en la Red en Infectología Pediátrica (RITIP), 28046 Madrid, Spain.
María Ángeles Muñoz-FernándezLaboratorio InmunoBiología Molecular, Sección Inmunología, Hospital General Universitario Gregorio Marañón and Spanish HIV HGM BioBank, Madrid Spain, Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 28007 Madrid, Spain.ORCID 0000-0002-0813-4500
Andrés MoyaÁrea Genómica y Salud, Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO), 46010 Valencia, Spain.ORCID 0000-0002-2867-1119
Maria Luisa NavarroRed de Investigación CoRISpe integrada en la Red en Infectología Pediátrica (RITIP), 28046 Madrid, Spain.
María José MelladoServicio de Pediatría, Hospital Universitario La Paz and IdiPAZ, 28046 Madrid, Spain.
Sergio Serrano-VillarServicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal and IRYCIS, 28034 Madrid, Spain.ORCID 0000-0002-5447-3554
Hospital Universitario La Paz · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHospital General Universitario Gregorio Marañón · ESInstituto Ramón y Cajal de Investigación Sanitaria · ESHospital Clínico San Carlos · ESHospital Universitario de Getafe · ESUniversitat de València · ES

Funding

Asociación Española contra en Cancer (AECC) AC17/00022Instituto de Salud Carlos III PI13/0422, PI15/00345, ICI14/00207, PI17/01283
6 · The paper itself

Abstract

aimsThe gut microbiota exerts a critical influence in the immune system. The gut microbiota of human virus immunodeficiency (HIV)-infected children remains barely explored. We aimed to characterize the fecal microbiota in vertically HIV-infected children and to explore the effects of its modulation with a symbiotic nutritional intervention.

methodsa pilot, double blind, randomized placebo-controlled study including HIV-infected children who were randomized to receive a nutritional supplementation including prebiotics and probiotics or placebo for four weeks. HIV-uninfected siblings were recruited as controls. The V3-V4 region of the 16S rRNA gene was sequenced in fecal samples.

results22 HIV-infected children on antiretroviral therapy (ART) and with viral load (VL) <50/mL completed the follow-up period. Mean age was 11.4 ± 3.4 years, eight (32%) were male. Their microbiota showed reduced alpha diversity compared to controls and distinct beta diversity at the genus level (Adonis

conclusionsVertical HIV infection is characterized by changes in gut microbiota structure, distinct at the compositional level from the findings reported in adults. A short nutritional intervention attenuated bacterial dysbiosis, without clear changes at the community level. SUMMARY: In a group of 24 vertically HIV-infected children, in comparison to 11 uninfected controls, intestinal dysbiosis was observed despite effective ART. Although not fully effective to restore the microbiota, a short intervention with pre/probiotics attenuated bacterial dysbiosis.

Indexed as

Dietary SupplementsGastrointestinal MicrobiomeInfectious Disease Transmission, VerticalAnti-Retroviral AgentsChildChild Nutritional Physiological PhenomenaChild, PreschoolDouble-Blind MethodDysbiosisFemaleHIV InfectionsHumansMalePilotsPrebioticsProbioticsAnti-Retroviral AgentsPrebioticschildren and adolescentsHIVmicrobiotavertical transmission

Identifiers

PMID32708743
PMCPMC7400861
OpenAlexW3043275270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.